Features Partner Sites Information LinkXpress hp
Sign In
Advertise with Us

Download Mobile App




Mechanical Stress May Induce Formation of Cancer Cells

By LabMedica International staff writers
Posted on 25 Jul 2012
Researchers have developed a novel technique for studying the forces that induce mistakes in chromosome distribution that have the potential to initiate growth of cancer cells.

In order to study mechanical effects that influence the outcome of cell division, investigators at the University of California, Los Angeles (USA) developed a novel microfluidic perfusion-culture system that allowed controllable variation in the level of cell confinement in a single axis allowing observation of cell growth and division at the single-cell level.

This novel culture platform allowed for both alterations in the geometry of the microenvironment, specifically the space in which the cell was allowed to grow and divide, as well as the elasticity of the substrate on which the cell was dividing. More...
By using the microfluidic device to compress the cells, the investigators minimized cell death due to lack of nutrients, as media was constantly perfused through the compression chamber. The device also allowed for facile imaging of cells, as they were in a single focal plane.

The investigators used this tool to study growth and division of single HeLa (human cervical carcinoma) cells. They reported in the June 25, 2012, online edition of the journal PLoS ONE that mechanically confined cell cycles resulted in stressed cell divisions that manifested as: (i) delayed mitosis, (ii) multidaughter mitosis events (from three up to five daughter cells), (iii) unevenly sized daughter cells, and (iv) induction of cell death. In the highest confined conditions, the frequency of divisions producing more than two progeny was increased 50-fold from unconfined environments, representing about one-half of all successful mitotic events. Most daughter cells resulting from multipolar divisions were viable after cytokinesis and were in some cases observed to re-fuse with neighboring cells post-cytokinesis.

“We hope that this platform will allow us to better understand how the 3-D mechanical environment may play a role in the progression of a benign tumor into a malignant tumor that kills," said senior author Dr. Dino Di Carlo, associate professor of bioengineering at the University of California, Los Angeles. “Even though cancer can arise from a set of precise mutations, the majority of malignant tumors possess aneuploid cells, and the reason for this is still an open question. Our new microfluidic platform offers a more reliable way for researchers to study how the unique tumor environment may contribute to aneuploidy.”

Related Links:
University of California, Los Angeles




Gold Member
Blood Gas Analyzer
Stat Profile pHOx
POC Helicobacter Pylori Test Kit
Hepy Urease Test
Clinical Chemistry System
P780
Automatic CLIA Analyzer
Shine i9000
Read the full article by registering today, it's FREE! It's Free!
Register now for FREE to LabMedica.com and get access to news and events that shape the world of Clinical Laboratory Medicine.
  • Free digital version edition of LabMedica International sent by email on regular basis
  • Free print version of LabMedica International magazine (available only outside USA and Canada).
  • Free and unlimited access to back issues of LabMedica International in digital format
  • Free LabMedica International Newsletter sent every week containing the latest news
  • Free breaking news sent via email
  • Free access to Events Calendar
  • Free access to LinkXpress new product services
  • REGISTRATION IS FREE AND EASY!
Click here to Register








Channels

Molecular Diagnostics

view channel
Image: The diagnostic device can tell how deadly brain tumors respond to treatment from a simple blood test (Photo courtesy of UQ)

Diagnostic Device Predicts Treatment Response for Brain Tumors Via Blood Test

Glioblastoma is one of the deadliest forms of brain cancer, largely because doctors have no reliable way to determine whether treatments are working in real time. Assessing therapeutic response currently... Read more

Immunology

view channel
Image: Circulating tumor cells isolated from blood samples could help guide immunotherapy decisions (Photo courtesy of Shutterstock)

Blood Test Identifies Lung Cancer Patients Who Can Benefit from Immunotherapy Drug

Small cell lung cancer (SCLC) is an aggressive disease with limited treatment options, and even newly approved immunotherapies do not benefit all patients. While immunotherapy can extend survival for some,... Read more

Microbiology

view channel
Image: New evidence suggests that imbalances in the gut microbiome may contribute to the onset and progression of MCI and Alzheimer’s disease (Photo courtesy of Adobe Stock)

Comprehensive Review Identifies Gut Microbiome Signatures Associated With Alzheimer’s Disease

Alzheimer’s disease affects approximately 6.7 million people in the United States and nearly 50 million worldwide, yet early cognitive decline remains difficult to characterize. Increasing evidence suggests... Read more

Technology

view channel
Image: Vitestro has shared a detailed visual explanation of its Autonomous Robotic Phlebotomy Device (photo courtesy of Vitestro)

Robotic Technology Unveiled for Automated Diagnostic Blood Draws

Routine diagnostic blood collection is a high‑volume task that can strain staffing and introduce human‑dependent variability, with downstream implications for sample quality and patient experience.... Read more

Industry

view channel
Image: Roche’s cobas® Mass Spec solution enables fully automated mass spectrometry in routine clinical laboratories (Photo courtesy of Roche)

New Collaboration Brings Automated Mass Spectrometry to Routine Laboratory Testing

Mass spectrometry is a powerful analytical technique that identifies and quantifies molecules based on their mass and electrical charge. Its high selectivity, sensitivity, and accuracy make it indispensable... Read more
Copyright © 2000-2026 Globetech Media. All rights reserved.